HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor.

Abstract
In our study of 6 month of pityriasis versicolor patient in skin department of Mymensingh Medical College Hospital outdoor, most of the patient was of age 16-25 years (63.33%), 20% was of age 26-35 years and 16.67% was of 36-45 years. Age distribution among male patient maximum (66.67%) was of 16-25 years and among females the maximum 50% was also of 16-25 years. Mostly was male (80%) and 20% was female only 20% of the patient has got the positive family history whereas 80% with no family history of the disease, which indicates that there is no hereditary predilection. Of the patient 66.67% was unmarried and 33.33% was married. Late adolescence & early adult age groups are predominantly affected. Small children & elderly adults are infected only in unusual circumstances, such as prolonged occlusion or immunosuppresion. Prevalence reported to be as high as 50% in the humid, hot environment of Western Samoa & on low as 11.1% in the colder temperature of Sweden. About sex distribution of patients 20% were female. The study shows that majority of patients were male (20%).
AuthorsN Muhammad, M Kamal, T Islam, N Islam, M Shafiquzzaman
JournalMymensingh medical journal : MMJ (Mymensingh Med J) Vol. 18 Issue 1 Pg. 31-5 (Jan 2009) ISSN: 1022-4742 [Print] Bangladesh
PMID19182746 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Antifungal Agents
  • Itraconazole
  • Fluconazole
  • Ketoconazole
Topics
  • Adolescent
  • Adult
  • Antifungal Agents (adverse effects, therapeutic use)
  • Bangladesh (epidemiology)
  • Female
  • Fluconazole (adverse effects, therapeutic use)
  • Humans
  • Incidence
  • Itraconazole (adverse effects, therapeutic use)
  • Ketoconazole (adverse effects, therapeutic use)
  • Male
  • Middle Aged
  • Prevalence
  • Risk Factors
  • Tinea Versicolor (drug therapy, epidemiology, pathology)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: